The absolute bioavailability of orally administered caffeine was investigated in 10 healthy adult male volunteers, aged 18.8 to 30.0 years. The subjects were administered a 5 mg/kg dose of caffeine as either an aqueous oral solution or an intravenous infusion, on separate occasions about 1 week apart, in a randomized crossover fashion. Plasma samples were collected over the 24-h period following each dose and assayed for their caffeine content using a high-performance liquid chromatographic technique. The oral absorption was very rapid, reaching a peak (Tp) plasma concentration after 29.8±8.1 min (mean±SEM). In addition, the variation in the maximum plasma concentration (Cmax) was low, 10.0±1.0 µg/ml. The absolute bioavailability was assessed by comparing the areas under the plasma concentration vs. time curves for the intravenous and oral doses of caffeine. The rapid absorption resulted in essentially complete bioavailability of the oral caffeine, F(%)=108.3±3.6%. The caffeine plasma half-lives varied from 2.7 to 9.9 h, indicating substantial inter-subject variability in its elimination.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Aldridge A, Parsons WD, Neims AH (1977) Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene. Life Sci 21: 967–974
Aranda JV, Cook CE, Gorman W, Collinge JM, Loughnan PM, Outerbridge EW, Aldridge A, Neims AH (1979) Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr 94: 663–668
Aranda JV, Gorman W, Bergsteinsson H, Gunn T (1977) Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J Pediatr 90: 467–472
Axelrod J, Reichenthal J (1953) The fate of caffeine in man and a method for its estimation in biological material. J Pharmacol Exp Ther 107: 519–523
Bada HS, Khanna NN, Somani SM, Tin AA (1979) Interconversion of theophylline and caffeine in newborn infants. J Pediatr 94: 993–995
Blanchard J, Mohammadi JD, Conrad KA (1980) Improved liquid-chromatographic determination of caffeine in plasma. Clin Chem 26: 1351–1354
Blanchard J, Mohammadi JD, Trang JM (1981) Elimination of a potential interference in assay for plasma caffeine. Clin Chem 27: 637–639
Boxenbaum HG, Riegelman S, Elashoff RM (1974) Statistical estimations in pharmacokinetics. J Pharmacokin Biopharm 2: 123–148
Chiou WL, Lui CY, Lam G (1981) Plasma area method in relative bioavailability evaluation of drugs with changing biological half-lives. J Pharm Sci 70: 109–112
Koup JR, Gibaldi M (1980) Some comments on the evaluation of bioavailability data. Drug Intell Clin Pharm 14: 327–330
Nelder JA, Mead R (1965) A simplex method for function minimization. Comput J 7: 308–313
Ottaway JH (1973) Normalization in the fitting of data by iterative methods. Biochem J 134: 729–736
Riggs DS (1963) The mathematical approach to physiological problems. Williams and Wilkins, Baltimore, MD, p 51
Rowland M (1980) Intra-individual variability in pharmacokinetics. In: Breimer DD (ed) Towards better safety of drugs and pharmaceutical products. Elsevier/North-Holland Biomedical Press, New York, pp 143–151
Tozer TN (1979) Pharmacokinetic principles relevant to bioavailability studies. In: Blanchard J, Sawchuk RJ, Brodie BB (eds) Principles and perspectives in drug bioavailability. Karger, Basel, pp 120–155
Upton RA, Riegelman S, Sheiner LB (1980) Bioavailability assessment as influenced by changes in drug disposition. In: Albert KS (ed) Drug absorption and disposition: statistical considerations. Am Pharm Assoc, Washington, DC, pp 77–86
About this article
Cite this article
Blanchard, J., Sawers, S.J.A. The absolute bioavailability of caffeine in man. Eur J Clin Pharmacol 24, 93–98 (1983). https://doi.org/10.1007/BF00613933
- absolute bioavailability
- intraand inter-subject variability